These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18195237)

  • 1. Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient.
    Saab G; Almony A; Blinder KJ; Schuessler R; Brennan DC
    Arch Ophthalmol; 2008 Jan; 126(1):140-1. PubMed ID: 18195237
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystoid macular edema associated with fingolimod use for multiple sclerosis.
    Afshar AR; Fernandes JK; Patel RD; Ksiazek SM; Sheth VS; Reder AT; Hariprasad SM
    JAMA Ophthalmol; 2013 Jan; 131(1):103-7. PubMed ID: 23307220
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of fingolimod-associated macular edema.
    Chui J; Herkes GK; Chang A
    JAMA Ophthalmol; 2013 May; 131(5):694-6. PubMed ID: 23538612
    [No Abstract]   [Full Text] [Related]  

  • 4. Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
    Minuk A; Belliveau MJ; Almeida DR; Dorrepaal SJ; Gale JS
    JAMA Ophthalmol; 2013 Jun; 131(6):802-4. PubMed ID: 23599188
    [No Abstract]   [Full Text] [Related]  

  • 5. Does fingolimod in multiple sclerosis patients cause macular edema?
    Turaka K; Bryan JS
    J Neurol; 2012 Feb; 259(2):386-8. PubMed ID: 22231867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
    Zarbin MA; Jampol LM; Jager RD; Reder AT; Francis G; Collins W; Tang D; Zhang X
    Ophthalmology; 2013 Jul; 120(7):1432-9. PubMed ID: 23531349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cystoid macular oedema after fingolimod treatment in multiple sclerosis].
    Asensio-Sánchez VM; Trujillo-Guzmán L; Ramoa-Osorio R
    Arch Soc Esp Oftalmol; 2014 Mar; 89(3):104-6. PubMed ID: 24269406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An effect of FTY720 on acute rejection in canine renal transplantation.
    Yuzawa K; Otsuka M; Taniguchi H; Takada Y; Sakurayama N; Jinzenji Y; Suzuki S; Fukao K
    Transplant Proc; 1998 Jun; 30(4):1046. PubMed ID: 9636422
    [No Abstract]   [Full Text] [Related]  

  • 9. Gilenya safety update: cardiac and macula.
    Huggins A; Sergott RC
    Curr Opin Ophthalmol; 2012 Nov; 23(6):457-9. PubMed ID: 23047163
    [No Abstract]   [Full Text] [Related]  

  • 10. Visual issues in multiple sclerosis.
    Francis CE
    Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):687-702. PubMed ID: 24314686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infections and fingolimod].
    Cervera C
    Rev Neurol; 2012 Aug; 55(4):227-37. PubMed ID: 22829086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famous.
    Kim MJ; Bhatti MT; Costello F
    Surv Ophthalmol; 2016; 61(4):512-9. PubMed ID: 26742785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingolimod-associated macular edema: incidence, detection, and management.
    Jain N; Bhatti MT
    Neurology; 2012 Feb; 78(9):672-80. PubMed ID: 22371414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720 in combination with CsA inhibits islet xenograft rejection: a study in the pig-to-rat model.
    Zhang J; Song Z; Wijkström M; Bari S; Sundberg B; Nava S; Groth CG; Korsgren O; Wennberg L
    Transplant Proc; 2000 Aug; 32(5):1017. PubMed ID: 10936327
    [No Abstract]   [Full Text] [Related]  

  • 15. [Molecular action mechanisms of the therapeutic agents for kidney diseases: Immunosuppressants].
    Nishikido M; Kanekake H; Harada T
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():634-8. PubMed ID: 16523968
    [No Abstract]   [Full Text] [Related]  

  • 16. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)].
    Popova NF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):110-3. PubMed ID: 21916166
    [No Abstract]   [Full Text] [Related]  

  • 17. FTY 720.
    Drugs R D; 1999 Jan; 1(1):78-80. PubMed ID: 10565994
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined use of FTY720 and cyclosporine A prevents chronic allograft vasculopathy.
    Koshiba T; Van Damme B; Lu Y; Yan Y; Rutgeerts O; Overbergh L; Tanaka K; Waer M; Mathieu C; Pirenne J
    Transplant Proc; 2002 May; 34(3):748-9. PubMed ID: 12034170
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumefactive multiple sclerosis and fingolimod.
    Lovera J; Villemarette-Pittman N
    J Neurol Sci; 2014 Sep; 344(1-2):1-2. PubMed ID: 24993468
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced macular edema.
    Makri OE; Georgalas I; Georgakopoulos CD
    Drugs; 2013 Jun; 73(8):789-802. PubMed ID: 23640687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.